{"result": "(\"entity\"<|>AMERICAN DIABETES ASSOCIATION<|>ORGANIZATION<|>The American Diabetes Association is an organization that provides guidelines and standards for diabetes care, including the management of diabetic neuropathy and cardiovascular health in diabetic patients.)\n##\n(\"entity\"<|>DIABETES CARE<|>ORGANIZATION<|>Diabetes Care is a journal that publishes research and guidelines related to diabetes management and care.)\n##\n(\"entity\"<|>NEUROPATHY<|>EVENT<|>Neuropathy is a condition that can occur in diabetic patients, characterized by nerve damage and various clinical manifestations.)\n##\n(\"entity\"<|>DIABETIC NEUROPATHY<|>EVENT<|>Diabetic neuropathy is a specific type of neuropathy that occurs in patients with diabetes, often requiring careful management and monitoring.)\n##\n(\"entity\"<|>CARDIOVASCULAR DISEASE<|>EVENT<|>Cardiovascular disease is a common complication in diabetic patients, which can lead to increased mortality and morbidity.)\n##\n(\"entity\"<|>DIABETES MELLITUS TYPE 1<|>EVENT<|>Diabetes Mellitus Type 1 is a form of diabetes that requires insulin management and is associated with various complications, including neuropathy.)\n##\n(\"entity\"<|>DIABETES MELLITUS TYPE 2<|>EVENT<|>Diabetes Mellitus Type 2 is a form of diabetes that can often be managed with lifestyle changes and medications, but also has complications like neuropathy.)\n##\n(\"relationship\"<|>AMERICAN DIABETES ASSOCIATION<|>DIABETES CARE<|>The American Diabetes Association provides guidelines that are often published in the journal Diabetes Care, which focuses on diabetes management<|>8)\n##\n(\"relationship\"<|>DIABETIC NEUROPATHY<|>NEUROPATHY<|>Diabetic neuropathy is a specific type of neuropathy that occurs as a complication of diabetes<|>9)\n##\n(\"relationship\"<|>DIABETES MELLITUS TYPE 1<|>DIABETIC NEUROPATHY<|>Diabetes Mellitus Type 1 can lead to diabetic neuropathy if not managed properly<|>7)\n##\n(\"relationship\"<|>DIABETES MELLITUS TYPE 2<|>DIABETIC NEUROPATHY<|>Diabetes Mellitus Type 2 can also lead to diabetic neuropathy, especially if glucose control is poor<|>7)\n##\n(\"relationship\"<|>DIABETES MELLITUS TYPE 1<|>CARDIOVASCULAR DISEASE<|>Patients with Diabetes Mellitus Type 1 are at increased risk for cardiovascular disease<|>6)\n##\n(\"relationship\"<|>DIABETES MELLITUS TYPE 2<|>CARDIOVASCULAR DISEASE<|>Patients with Diabetes Mellitus Type 2 are also at increased risk for cardiovascular disease<|>6)\n<|COMPLETE|>", "input": "\n-Goal-\nGiven a text document that is potentially relevant to this activity and a list of entity types, identify all entities of those types from the text and all relationships among the identified entities.\n \n-Steps-\n1. Identify all entities. For each identified entity, extract the following information:\n- entity_name: Name of the entity, capitalized\n- entity_type: One of the following types: [organization,person,geo,event]\n- entity_description: Comprehensive description of the entity's attributes and activities\nFormat each entity as (\"entity\"<|><entity_name><|><entity_type><|><entity_description>)\n \n2. From the entities identified in step 1, identify all pairs of (source_entity, target_entity) that are *clearly related* to each other.\nFor each pair of related entities, extract the following information:\n- source_entity: name of the source entity, as identified in step 1\n- target_entity: name of the target entity, as identified in step 1\n- relationship_description: explanation as to why you think the source entity and the target entity are related to each other\n- relationship_strength: a numeric score indicating strength of the relationship between the source entity and target entity\n Format each relationship as (\"relationship\"<|><source_entity><|><target_entity><|><relationship_description><|><relationship_strength>)\n \n3. Return output in English as a single list of all the entities and relationships identified in steps 1 and 2. Use **##** as the list delimiter.\n \n4. When finished, output <|COMPLETE|>\n \n######################\n-Examples-\n######################\nExample 1:\nEntity_types: ORGANIZATION,PERSON\nText:\nThe Verdantis's Central Institution is scheduled to meet on Monday and Thursday, with the institution planning to release its latest policy decision on Thursday at 1:30 p.m. PDT, followed by a press conference where Central Institution Chair Martin Smith will take questions. Investors expect the Market Strategy Committee to hold its benchmark interest rate steady in a range of 3.5%-3.75%.\n######################\nOutput:\n(\"entity\"<|>CENTRAL INSTITUTION<|>ORGANIZATION<|>The Central Institution is the Federal Reserve of Verdantis, which is setting interest rates on Monday and Thursday)\n##\n(\"entity\"<|>MARTIN SMITH<|>PERSON<|>Martin Smith is the chair of the Central Institution)\n##\n(\"entity\"<|>MARKET STRATEGY COMMITTEE<|>ORGANIZATION<|>The Central Institution committee makes key decisions about interest rates and the growth of Verdantis's money supply)\n##\n(\"relationship\"<|>MARTIN SMITH<|>CENTRAL INSTITUTION<|>Martin Smith is the Chair of the Central Institution and will answer questions at a press conference<|>9)\n<|COMPLETE|>\n\n######################\nExample 2:\nEntity_types: ORGANIZATION\nText:\nTechGlobal's (TG) stock skyrocketed in its opening day on the Global Exchange Thursday. But IPO experts warn that the semiconductor corporation's debut on the public markets isn't indicative of how other newly listed companies may perform.\n\nTechGlobal, a formerly public company, was taken private by Vision Holdings in 2014. The well-established chip designer says it powers 85% of premium smartphones.\n######################\nOutput:\n(\"entity\"<|>TECHGLOBAL<|>ORGANIZATION<|>TechGlobal is a stock now listed on the Global Exchange which powers 85% of premium smartphones)\n##\n(\"entity\"<|>VISION HOLDINGS<|>ORGANIZATION<|>Vision Holdings is a firm that previously owned TechGlobal)\n##\n(\"relationship\"<|>TECHGLOBAL<|>VISION HOLDINGS<|>Vision Holdings formerly owned TechGlobal from 2014 until present<|>5)\n<|COMPLETE|>\n\n######################\nExample 3:\nEntity_types: ORGANIZATION,GEO,PERSON\nText:\nFive Aurelians jailed for 8 years in Firuzabad and widely regarded as hostages are on their way home to Aurelia.\n\nThe swap orchestrated by Quintara was finalized when $8bn of Firuzi funds were transferred to financial institutions in Krohaara, the capital of Quintara.\n\nThe exchange initiated in Firuzabad's capital, Tiruzia, led to the four men and one woman, who are also Firuzi nationals, boarding a chartered flight to Krohaara.\n\nThey were welcomed by senior Aurelian officials and are now on their way to Aurelia's capital, Cashion.\n\nThe Aurelians include 39-year-old businessman Samuel Namara, who has been held in Tiruzia's Alhamia Prison, as well as journalist Durke Bataglani, 59, and environmentalist Meggie Tazbah, 53, who also holds Bratinas nationality.\n######################\nOutput:\n(\"entity\"<|>FIRUZABAD<|>GEO<|>Firuzabad held Aurelians as hostages)\n##\n(\"entity\"<|>AURELIA<|>GEO<|>Country seeking to release hostages)\n##\n(\"entity\"<|>QUINTARA<|>GEO<|>Country that negotiated a swap of money in exchange for hostages)\n##\n##\n(\"entity\"<|>TIRUZIA<|>GEO<|>Capital of Firuzabad where the Aurelians were being held)\n##\n(\"entity\"<|>KROHAARA<|>GEO<|>Capital city in Quintara)\n##\n(\"entity\"<|>CASHION<|>GEO<|>Capital city in Aurelia)\n##\n(\"entity\"<|>SAMUEL NAMARA<|>PERSON<|>Aurelian who spent time in Tiruzia's Alhamia Prison)\n##\n(\"entity\"<|>ALHAMIA PRISON<|>GEO<|>Prison in Tiruzia)\n##\n(\"entity\"<|>DURKE BATAGLANI<|>PERSON<|>Aurelian journalist who was held hostage)\n##\n(\"entity\"<|>MEGGIE TAZBAH<|>PERSON<|>Bratinas national and environmentalist who was held hostage)\n##\n(\"relationship\"<|>FIRUZABAD<|>AURELIA<|>Firuzabad negotiated a hostage exchange with Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>AURELIA<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>FIRUZABAD<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>ALHAMIA PRISON<|>Samuel Namara was a prisoner at Alhamia prison<|>8)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>MEGGIE TAZBAH<|>Samuel Namara and Meggie Tazbah were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>DURKE BATAGLANI<|>Samuel Namara and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>DURKE BATAGLANI<|>Meggie Tazbah and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>FIRUZABAD<|>Samuel Namara was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>FIRUZABAD<|>Meggie Tazbah was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>DURKE BATAGLANI<|>FIRUZABAD<|>Durke Bataglani was a hostage in Firuzabad<|>2)\n<|COMPLETE|>\n\n######################\n-Real Data-\n######################\nEntity_types: organization,person,geo,event\nText: : Standards of Medical Care in Diabetes-2019.\n             primeros indicios de neuropatía diabética.                                                             Diabetes Care. 2019;42(Suppl 1):S124-38.\n         C. La disfunción eréctil puede ocurrir en ausencia de otros signos de neuropatía vegetativa\n             diabética.\n         D.  Todas las respuestas anteriores son correctas.                                                   52  En la evaluación de la polineuropatía diabética, señale la respuesta falsa:\n                                                                                                                  A. Se evalúa la función de las fibras gruesas mediante un diapasón de 128 Hz.\n     51  En relación con la neuropatía diabética, señale cuál de las siguientes afirmaciones                      B. Se evalúa la función de las fibras gruesas mediante la valoración de la sensibilidad\n         es verdadera:                                                                                                térmica.\n         A. La neuropatía diabética es siempre difusa.                                                            C. Se trata de un diagnóstico de exclusión.\n         B. La neuropatía autonómica cardíaca se caracteriza por un ritmo cardíaco fijo, que                      D.  Se evalúa la función de las fibras finas mediante la valoración de la sensibilidad algésica\n             responde mínimamente a estímulos fisiológicos como la respiración profunda.                              (Pinprick).\n         C. La neuropatía diabética responde habitualmente al tratamiento con inhibidores de la\n             enzima de conversión.                                                                                COMENTARIO\n         D.  La mejoría del control glucémico con insulina es más eficaz que si se obtiene con                    La neuropatía diabética es un diagnóstico de exclusión. Las neuropatías no diabéticas pue-\n             antidiabéticos orales para el alivio de los síntomas de la neuropatía diabética..                    den estar presentes en pacientes con diabetes y pueden ser tratables.\n         COMENTARIO                                                                                               Las siguientes pruebas clínicas se pueden usar para evaluar la función de las fibras grandes\n                                                                                                                  y pequeñas y la sensación de protección:\n         Las neuropatías diabéticas son un grupo heterogéneo de trastornos con diversas manifes-                  1.  Función de pequeña fibra: pinchazo y sensación de temperatura.\n         taciones clínicas. Se debe optimizar el control de la glucosa para prevenir o retrasar el desa-          2.  Función de fibra grande: percepción de vibración y monofilamento de 10 g.\n         rrollo de la neuropatía en pacientes con DM1 y para retardar la progresión de la neuropatía              3.  Sensación protectora: monofilamento de 10 g.\n         en pacientes con DM2. El tratamiento específico para el daño nervioso subyacente, que no\n         sea un control glucémico mejorado, actualmente no está disponible.                                       Estas pruebas no solo detectan la presencia de disfunción, sino que también predicen el\n         La neuropatía diabética es un diagnóstico de exclusión. Las neuropatías no diabéticas pue-               riesgo futuro de complicaciones.\n         den estar presentes en pacientes con diabetes y pueden ser tratables.                                    Referencias:\n         Hasta el 50% de las neuropatías periféricas diabéticas pueden ser asintomáticas. Si no se                • American Diabetes Association. Microvascular Complications and Foot Care: Standards of Medical Care in Diabetes-2019. Diabetes\n                                                                                                                    Care. 2019;42(Suppl 1):S124-38.\n         reconoce y si no se implementa el cuidado preventivo de los pies, los pacientes corren el\n         riesgo de sufrir lesiones en los pies insensibles.\n\n\n\n112                                                                                                                                                                                                                                         113\n---\n                                                                                                                                                                                                                   DIABETES                          2\n\n\n\n     53  En relación con la enfermedad cardíaca en el diabético, indique cuál de las                                        Por la eficacia probada del tratamiento con betabloqueantes en pacientes con síndrome co-\n         siguientes afirmaciones es verdadera:                                                                              ronario agudo, y por la ausencia de perjuicio en el síndrome coronario agudo sin elevación\n                                                                                                                            del ST y en la angina inestable, los betabloqueantes deben ser introducidos, dentro de las\n         A. La mortalidad del infarto de miocardio en un diabético es similar a la de un no diabético.                      primeras 24 h, salvo que exista contraindicación por inestabilidad hemodinámica. Los beta-\n         B. La diabetes se asocia con un incremento de la insuficiencia cardíaca, incluso tras ajustar                      bloqueantes cardioselectivos son de elección.\n              con otros factores de riesgo como presión arterial, nivel de colesterol y edad.                               Referencias:\n         C. La reducción de los niveles de colesterol LDL apenas produce beneficio clínico para                             • Amsterdam EA, Wenger NK, Brindis RG, Casey DE Jr, Ganiats TG, Holmes DR Jr, et al. ACC/AHA Task Force Members, Society for\n              disminuir eventos cardiovasculares en los pacientes con diabetes.                                               Cardiovascular\n######################\nOutput:", "parameters": {"model": "gpt-4o-mini", "temperature": 0.0, "frequency_penalty": 0.0, "presence_penalty": 0.0, "top_p": 1.0, "max_tokens": 4000, "n": 1}, "history": null}